Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

After 20 Years, Scientists Crack HIV Puzzle

Enzyme integrase made visible for first time

By Jane Yager, Newser Staff

Posted Feb 1, 2010 8:11 AM CST

(Newser) – After 40,000 failed trials and "painstakingly slow progress," scientists have solved a puzzle that stumped AIDS researchers for more than 20 years—and their findings could help develop more effective HIV drugs. The researchers at Harvard and Imperial College London grew a... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

24 comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

'Serpent Pastor' Dies of Snake Bite

Miami Face-Eater Identified

Reuters (Source Grid »)

Health

drugs • AIDS • Merck • HIV • pharmaceutical • enzyme • AIDS vaccine • HIV/AIDS • drug cocktail • AIDS epidemic • Gilead Sciences • integrase

More Newser Stories

FDA Panel Backs First Drug to Block HIV

Truvada, made by Gilead Sciences, is for healthy people at risk

(AP) - A panel of federal health advisers has endorsed the first drug shown to prevent HIV infection in healthy people, clearing the way for a potentially landmark approval in the 30-year-old effort against the virus that causes AIDS. In a series of votes, the FDA advisory panel recommended approval of the daily pill Truvada for healthy people who are at high risk of contracting HIV, including gay and bisexual men, and heterosexual couples with one HIV-infected person. More»

Contraceptive Shot May Double HIV Risk

Study findings could present a 'major health crisis'

(NEWSER) - Alarming new research out of eastern and southern Africa, where both unplanned pregnancies and AIDS wreak havoc: The most popular contraceptive used by women there appears to double their risk of contracting HIV—and if a woman already has HIV, it doubles her risk of transmitting it to her partner compared to women who use no contraception. The study centers around a hormone shot given once every three months, which is the best contraception available in Africa today, one expert tells the New York Times : “If it is now proven that these contraceptions are helping spread the AIDS epidemic, we have a major health crisis on our hands.” More»

Scientists Find Trick to 'Disarm' HIV

Without its cholesterol, virus can't harm immune system

(NEWSER) - A group of US and European scientists have discovered a way to prevent the HIV virus from harming the immune system, in a breakthrough that could lead to an entirely new approach to fighting AIDS. They discovered that by extracting cholesterol, they could render the virus a sitting duck for the immune system’s adaptive response. “It’s like an army that has lost its weapons but still has flags, so another army can recognize it and attack it,” the study’s leader explained to Reuters . More»

AIDS Drugs Slash Risk of Getting HIV in First Place

Pair of studies show minimum 60% drop in infection rate

(NEWSER) - The same antiretroviral drugs that treat HIV and AIDS can also be used to cut down the risk of contracting HIV in the first place, two new studies show. The dramatic results are just the latest evidence that AIDS drugs can be effective at prevention as well as treatment. While previous research has shown antiretroviral drugs to be effective for specific groups, the new studies, carried out in Kenya, Uganda, and Botswana, show that they are also effective in the general heterosexual population. More»

Scientists Find HIV's Achilles Heel

Vaccines should target one area, not the entire virus, new research suggests

(NEWSER) - Scientists have made an important breakthrough in HIV research, and we have the stock market to thank. Researchers used random matrix theory, which is also used to analyze stock behavior, to identify a major target for HIV and AIDS drugs—what the Wall Street Journal calls its “Achilles heel.” The research suggests that an HIV vaccine should focus on a few targets, instead of waging a broad war on the virus. Basically, this method is what a small group of patients—who control the virus without medication—known as “elite controllers” do naturally. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

After 20 Years, Scientists Crack HIV Puzzle

Enzyme integrase made visible for first time

drugs • AIDS • Merck • HIV • pharmaceutical • enzyme • AIDS vaccine • HIV/AIDS • drug cocktail • AIDS epidemic • Gilead Sciences • integrase

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

FDA Panel Backs First Drug to Block HIV

Truvada, made by Gilead Sciences, is for healthy people at risk

Contraceptive Shot May Double HIV Risk

Study findings could present a 'major health crisis'

Scientists Find Trick to 'Disarm' HIV

Without its cholesterol, virus can't harm immune system

AIDS Drugs Slash Risk of Getting HIV in First Place

Pair of studies show minimum 60% drop in infection rate

Scientists Find HIV's Achilles Heel

Vaccines should target one area, not the entire virus, new research suggests

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?